Clinical Trial Update: Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 trial comparing otamixaban to unfractionated heparin plus eptifibatide in patients with unstable angina or non-ST-elevation myoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Myocardial Infarction
• Unstable Angina

Drugs mentioned

• EPTIFIBATIDE (EPTIFIBATIDE)
• Otamixaban (otamixaban)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Sanofi | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED